NASDAQ:PTEPolarityte Stock Price, Forecast & News

Polarityte's stock was trading at $1.07 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PTE shares have decreased by 8.7% and is now trading at $0.9764. View which stocks have been most impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Polarityte in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Polarityte.

Polarityte Inc (NASDAQ:PTE) announced its quarterly earnings data on Monday, May, 11th. The company reported ($0.39) EPS for the quarter, beating analysts' consensus estimates of ($0.57) by $0.18. The business earned $0.93 million during the quarter, compared to the consensus estimate of $1.27 million. Polarityte had a negative net margin of 1,561.72% and a negative return on equity of 157.30%. During the same period in the previous year, the firm earned ($1.18) EPS. View Polarityte's earnings history.

5 brokers have issued 12 month price targets for Polarityte's stock. Their forecasts range from $3.00 to $8.00. On average, they expect Polarityte's stock price to reach $5.40 in the next twelve months. This suggests a possible upside of 453.1% from the stock's current price. View analysts' price targets for Polarityte.

Media coverage about PTE stock has been trending very negative recently, according to InfoTrie Sentiment. The research firm rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Polarityte earned a news impact score of -3.7 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news aboutPolarityte.

Polarityte saw a decrease in short interest in the month of April. As of April 15th, there was short interest totaling 3,090,000 shares, a decrease of 6.4% from the March 31st total of 3,300,000 shares. Based on an average daily volume of 563,600 shares, the days-to-cover ratio is presently 5.5 days. Currently, 13.4% of the company's stock are short sold. View Polarityte's Current Options Chain.

Some companies that are related to Polarityte include Erytech Pharma (ERYP), Cidara Therapeutics (CDTX), Surface Oncology (SURF), Solid Biosciences (SLDB), X4 Pharmaceuticals (XFOR), Gamida Cell (GMDA), BIONDVAX PHARMA/S (BVXV), La Jolla Pharmaceutical (LJPC), Applied Genetic Technologies (AGTC), Champions Oncology (CSBR), Windtree Therapeutics (WINT), Outlook Therapeutics (OTLK), Neon Therapeutics (NTGN), Organovo (ONVO) and Genocea Biosciences (GNCA). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Polarityte investors own include Amplify Energy (AMPY), Amplify Energy (AMPY), Outlook Therapeutics (OTLK), Unum Therapeutics (UMRX), BioNano Genomics (BNGO), Seanergy Maritime (SHIP), Ekso Bionics (EKSO), Matinas BioPharma (MTNB), OrganiGram (OGI) and Titan Pharmaceuticals (TTNP).

Polarityte trades on the NASDAQ under the ticker symbol "PTE."

Polarityte's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (3.30%), Sabby Management LLC (0.91%), State Street Corp (0.82%), Geode Capital Management LLC (0.81%), Advisor Group Holdings Inc. (0.50%) and Levin Capital Strategies L.P. (0.40%). Company insiders that own Polarityte stock include Cameron J Hoyler, David B Seaburg, Denver Lough, Edward Winslow Swanson, Paul Elliot Mann, Peter A Cohen, Rainer M Erdtmann, Richard Hague and Steve Gorlin. View institutional ownership trends for Polarityte.

PTE stock was purchased by a variety of institutional investors in the last quarter, including Sabby Management LLC, Advisor Group Holdings Inc., BlackRock Inc., State Street Corp, Geode Capital Management LLC, Levin Capital Strategies L.P., LWS Wealth Advisors Inc., and Capital Wealth Alliance LLC. Company insiders that have bought Polarityte stock in the last two years include Edward Winslow Swanson, Paul Elliot Mann, Peter A Cohen, and Rainer M Erdtmann. View insider buying and selling activity for Polarityte.

Shares of PTE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PTE stock can currently be purchased for approximately $0.98.

Polarityte has a market capitalization of $37.55 million and generates $5.65 million in revenue each year. The company earns $-92,490,000.00 in net income (profit) each year or ($3.70) on an earnings per share basis. Polarityte employs 153 workers across the globe.

The official website for Polarityte is www.polarityte.com.

Polarityte's mailing address is 123 NORTH WRIGHT BROTHERS DRIVE, SALT LAKE CITY UT, 84116. The company can be reached via phone at 385-237-2279 or via email at [email protected]